24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Do Immune-Based Cancer Drugs Work Better in Men?Gene Found in Amish Helps Protect Their HeartsOmicron May Overcome Prior COVID InfectionWindy Days Are Safer Days When It Comes to COVID-19Most Vaccinated Adults Plan to Get Boosters: PollStudy Finds Delta Somewhat Resistant to Vaccines — What About Omicron?Is the Mumps Vaccine Becoming Less Effective?Vaping Can Trigger Gene Changes in Cells: StudyPfizer or Moderna? Head-to-Head Study Shows One Shot Has an EdgeSurvivors of Severe COVID Face Doubled Risk for Death a Year LaterKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionFirst U.S. Omicron Case Reported in California'Ultra-Processed' Foods Up Odds for a Second Heart Attack or StrokeCDC to Toughen COVID Testing for International TravelersAHA News: Irregular Heartbeat Risk Linked to Frequent Alcohol Use in People Under 40Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryFDA Panel Gives Support to Merck's COVID Antiviral PillLong-Haul COVID Can Include Chronic Fatigue: StudyVaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: FauciPfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron VariantCOVID May Trigger Heart Condition in Young AthletesMany People With High Blood Pressure May Take a Drug That Worsens It: StudyBiden Pushes Vaccines, Masks as Best Defense Against Omicron VariantHow Easily Can Singing Spread COVID-19?New Insights Into What Might Drive Parkinson's DiseaseHot Days Can Send Even Younger Folks to the ERRed Light in Morning May Protect Fading Eyesight: StudyMerck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDAVaccine Makers Already Testing Their Shots Against Omicron VariantWhat Experts Know About the Omicron 'Variant of Concern'Gout Drug Colchicine Won't Help Fight COVID-19What You Need to Know About Stomach CancerFetal Infection With COVID-19 Possible, But UnlikelyCOVID Protection Wanes After 2 Doses of Pfizer Vaccine: StudyRural Hospitals' ERs Just as Effective as Urban Ones: Study1 in 5 Avoided Health Care During Pandemic, Study FindsBoosters: What You Need to KnowAHA News: Pulmonary Embolism Is Common and Can Be Deadly, But Few Know the SignsAlmost 1 in Every 3 College-Age Americans Are Now ObeseAnimal Study Offers Hope for a Vaccine Against Lyme DiseaseAddictive Opioid Painkillers Might Not Be Needed After Knee SurgeryYears of Blood Thinners After Stenting Might Not Be NecessaryU.S. COVID Cases, Hospitalizations on the Rise Just Before ThanksgivingVaping Could Weaken Your Bones, Study FindsWearable Vibration Device May Ease Parkinson's TremorPfizer Says Its COVID Vaccine Provides Full Protection to AdolescentsBooster Shots Prompt Stronger, Longer Protection Than Original Shots: StudyTV Remotes, Nurse Call Buttons: Where Coronavirus Lingers in Nursing Homes
Questions and AnswersLinks
Related Topics

Diabetes

CDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match Shots

HealthDay News
by By Robin Foster HealthDay Reporter
Updated: Oct 22nd 2021

new article illustration

FRIDAY, Oct. 22, 2021 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Thursday gave its blessing to booster shots of the Moderna and Johnson & Johnson coronavirus vaccines for tens of millions of Americans.

The CDC approval mirrors the one granted by the U.S. Food and Drug Administration on Wednesday and follows its own endorsement last month of Pfizer booster shots. Now, many Americans will be able to get a booster shot as early as Friday, health officials said. Importantly, the CDC also endorsed the mixing and matching of vaccines, giving state and local health officials greater flexibility in getting booster shots to Americans who need them.

"The evidence shows that all three COVID-19 vaccines authorized in the United States are safe -- as demonstrated by the over 400 million vaccine doses already given. And, they are all highly effective in reducing the risk of severe disease, hospitalization and death, even in the midst of the widely circulating Delta variant," CDC Director Dr. Rochelle Walensky said in a statement released Thursday evening. Earlier in the day, the CDC's vaccine advisory panel endorsed both booster shots and mixing and matching vaccines.

The news will be particularly reassuring for the 15 million Americans who got the Johnson & Johnson vaccine, many of whom have been afraid that they are vulnerable to breakthrough infections because of that shot's lower level of protection.

"I agree that those who received a [Johnson & Johnson] vaccine should receive a second dose — I would prefer that those individuals get an mRNA vaccine [Pfizer of Moderna]" rather than a second Johnson & Johnson shot, said CDC vaccine advisory panel member Pablo J. Sanchez, a pediatrician at Ohio State University, the Washington Post reported.

"I think the opportunity for these [mix and match] boosts [is] priceless," said Helen Keipp Talbot, an infectious disease doctor at Vanderbilt University and CDC vaccine advisory panel member, the Post reported.

The CDC plans to release guidance early next week about who might benefit from choosing one booster over another, as its advisory panel requested. CDC advisers and agency officials are still working out whether to recommend that some people stick to their original vaccine if possible.

In its Wednesday approval, the FDA recommended that:

  • People who received Moderna vaccine can get a booster at least six months after they have completed the two-dose series, if they are 65 or older, at high risk of severe disease, or work in jobs that regularly expose them to COVID-19.
  • Anyone over 18 who got the single-dose Johnson & Johnson vaccine can get a booster shot two months after they got the first jab.
  • Any person eligible for a booster dose can "mix and match" their extra jab, regardless of the vaccine they were initially given.

"Today, the currently available data suggest waning immunity in some populations of fully vaccinated people, and the availability of these authorized boosters is important for continued protection against COVID-19 disease," acting FDA Commissioner Dr. Janet Woodcock said during a Wednesday media briefing on the agency's booster approvals.

The guidelines for Moderna vaccine recipients eligible for a booster shot echo those set late last month for people who got the Pfizer vaccine.

One difference -- the Moderna booster will be a half-dose of the original vaccine, while the Pfizer booster is a full dose, the FDA said.

The agency also authorized "mix-and-match" booster doses after reviewing clinical trial data showing that an extra shot of any vaccine will provide added protection to anyone who's developed vaccine immunity, the FDA said.

"In many ways, as we move to deal with this as an infectious disease that we have to deal with, being able to interchange these vaccines is a good thing," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said during the Wednesday media briefing. "It's like what we do with flu vaccine. Most people don't know what brand flu vaccine they receive."

"If people have concerns, they should ask their providers and there might be reasons why an individual provider might decide to recommend a different booster based on side effects that were seen" during their initial series of shots, he added.

In the National Institutes of Health study on "mix-and-match" COVID-19 boosters, researchers looked at nine groups of roughly 50 people each. Each group received one of the three authorized vaccines, followed by a booster. In three groups, volunteers received the same vaccine for a boost. In the other six, they got a different vaccine.

The differences were startling: Those who got a J&J shot followed by a Moderna booster saw their antibody levels rise 76-fold within 15 days, while those who got a second dose of the J&J vaccine saw only a fourfold rise during the same period. A Pfizer booster shot raised antibody levels in Johnson & Johnson recipients 35-fold.

Nirav Shah, president of the Association of State and Territorial Health Officials, told the Post that the approval of the mix-and-match approach would make outreach efforts for boosters a simpler task.

The ability to mix and match boosters means that "when our teams are going into a community or a nursing facility to provide boosters, being able to carry one vaccine and give it to all who are eligible speeds up the process," Shah explained.

Meanwhile, regulators are seriously considering authorizing booster shots for people as young as 40, according to two officials familiar with the plans, the Post reported. That would not happen until the pediatric vaccine is authorized, said the officials, who spoke on the condition of anonymity.

About 105 million fully vaccinated people have received the two-shot Pfizer series, according to the CDC. About 70 million fully vaccinated people have received the Moderna shots. Only 15 million Americans were vaccinated with Johnson & Johnson shots, which arrived later and were delayed by an investigation of a rare adverse event, as well as a manufacturing problem. More than 11 million people have received a booster or an additional dose of a vaccine to date.

More information

Visit the U.S. Food and Drug Administration for more on COVID vaccines.


SOURCE: U.S. Centers for Disease Control and Prevention, news release, Oct. 21, 2021; Oct. 20, 2021, media briefing with: Janet Woodcock, MD, acting commissioner, U.S. Food and Drug Administration, and Peter Marks, M.D., Ph.D., director, FDA's Center for Biologics Evaluation and Research; U.S. Food and Drug Administration, news release, Oct. 20, 2021; Washington Post